SEC Filings

Form 424B5
PROTAGONIST THERAPEUTICS, INC filed this Form 424B5 on 08/07/2018
Document Outline
Entire Document (374.3 KB)
Subdocument 1 - 424B5 - 424B5
Page 1 - Filed Pursuant to Rule 424(b)(5)
Page 2 - TABLE OF CONTENTS
Page 3 - ABOUT THIS PROSPECTUS SUPPLEMENT
Page 4 - N/A
Page 5 - PROSPECTUS SUPPLEMENT SUMMARY
Page 6 - Janssen License and Collaboration Agreement
Page 7 - Recent Developments
Page 8 - Company Information
Page 9 - THE OFFERING
Page 10 - RISK FACTORS
Page 11 - Additional Risks Related to our Business
Page 12 - We are heavily dependent on the success of our lead product candidates, PTG-100, PTG-200 and PTG-300
Page 13 - N/A
Page 14 - N/A
Page 15 - FORWARD-LOOKING STATEMENTS
Page 16 - USE OF PROCEEDS
Page 17 - DIVIDEND POLICY
Page 18 - CAPITALIZATION
Page 19 - DILUTION
Page 20 - PRIVATE PLACEMENT TRANSACTION
Page 21 - PLAN OF DISTRIBUTION
Page 22 - LEGAL MATTERS
Page 23 - INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
Page 24 - PROSPECTUS
Page 25 - TABLE OF CONTENTS
Page 26 - N/A
Page 27 - SUMMARY
Page 28 - Janssen Collaboration Agreement
Page 29 - Company Information
Page 30 - THE SECURITIES WE MAY OFFER
Page 31 - N/A
Page 32 - N/A
Page 33 - RISK FACTORS
Page 34 - N/A
Page 35 - FINANCIAL RATIOS
Page 36 - DESCRIPTION OF CAPITAL STOCK
Page 37 - N/A
Page 38 - Options
Page 39 - Form S-3 registration rights
Page 40 - N/A
Page 41 - Transfer Agent and Registrar
Page 42 - DESCRIPTION OF DEBT SECURITIES
Page 43 - N/A
Page 44 - Conversion or Exchange Rights
Page 45 - N/A
Page 46 - Modification of Indenture; Waiver
Page 47 - Discharge
Page 48 - Information Concerning the Trustee
Page 49 - LEGAL OWNERSHIP OF SECURITIES
Page 50 - Legal Holders
Page 51 - Special Considerations for Global Securities
Page 52 - N/A
Page 53 - PLAN OF DISTRIBUTION
Page 54 - N/A
Page 55 - N/A
Page 56 - LEGAL MATTERS
Page 57 - INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
Page 58 - 2,750,000 Shares